REGN
Regeneron Pharmaceuticals Inc · Healthcare
About REGN
Regeneron Pharmaceuticals Inc (REGN) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.
No financial statements are available from the consulted sources; missing figures must not be interpreted as zero.
Dividends and distributions · last 12 records
The source returned no recent distributions for this asset.
SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.
Income statement, balance sheet and cash flow
Financial statements are not available for this asset yet.
Frequently asked questions
What is the price of REGN?
The reference price available for REGN is $753.12.
What is the P/E of REGN?
The P/E ratio of REGN is 18.61. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.
What is the P/B of REGN?
The P/B of REGN is 2.46. This compares price with reported book value per share.
What is the ROE of REGN?
The ROE (Return on Equity) of REGN is 14.04%. This relates the reported net result to shareholders' equity.
What is the dividend yield of REGN?
The dividend yield of REGN is 0.47%. The provider may use annualized dividends; this is not a guaranteed return.
What is the market cap of REGN?
The market capitalization of REGN is US$ 77.5 B.
What is the net margin of REGN?
The net profit margin of REGN is 27.86%. This relates the reported net result to revenue.
What is the net debt-to-equity ratio of REGN?
The reported net debt-to-equity ratio of REGN is 0.09. This compares net debt, after cash, with shareholders' equity.
What sector is REGN in?
REGN operates in the Healthcare sector.